Abstract
At the European Society of Paediatric Radiology (ESPR) annual meeting 2017 in Davos, Switzerland, the ESPR Abdominal (gastrointestinal and genitourinary) Imaging Task Force set out to complete the suggestions for paediatric abdominal imaging and its procedural recommendations. Some final topics were addressed including how to perform paediatric gastrointestinal ultrasonography. Based on the recent approval of ultrasound (US) contrast agents for paediatric use, important aspects of paediatric contrast-enhanced US were revisited. Additionally, the recent developments concerning the use and possible brain deposition of gadolinium as a magnetic resonance imaging contrast agent were presented. The recommendations for paediatric use were reissued after considering all available evidence. Recent insights on the incidence of neoplastic lesions in children with testicular microlithiasis were discussed and led to a slightly altered recommendation.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
H.-J. Mentzel has received funding from Bayer Schering for studies on Magnevist and Gadovist in children. No further disclosures. M Riccabona has recieved support from Bracco for Symposia on childhood CEUS.
Selected literature
General
Taylor SA, Avni FE, Cronin CG et al (2017) The first joint ESGAR/ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging. Eur Radiol 27:2570–2582
Riccabona M, Lobo ML, Ording-Muller LS et al (2017) ESPR abdominal (GU and GI) imaging task force – imaging recommendations in paediatric uroradiology, part IX: imaging in anorectal and cloacal malformation, imaging in childhood ovarian torsion, and efforts in standardising pediatric uroradiology terminology. Report on the mini-symposium at the ESPR meeting in Graz, June 2015. Pediatr Radiol 46:1369–1380
Riccabona M, Darge K, Lobo ML et al (2015) ESPR Uroradiology task force – imaging recommendations in paediatric uroradiology - part VIII: retrograde urethrography, imaging in disorders of sexual development, and imaging in childhood testicular torsion. Report on the mini-symposium at the ESPR meeting in Amsterdam, June 2014. Pediatr Radiol 45:2023–2028
Riccabona M, Vivier HP, Ntoulj A et al (2014) ESPR Uroradiology task force – imaging recommendations in paediatric uroradiology - part VII: standardized terminology, impact of existing recommendations, and update on contrast-enhanced ultrasound of the paediatric urogenital tract. Pediatr Radiol 44:1478–1484
Riccabona M, Lobo ML, Willi U et al (2014) ESPR Uroradiology task force and ESUR Paediatric working group - imaging recommendations in paediatric uroradiology, part VI: childhood renal biopsy and imaging of neonatal and infant genital tract. Pediatr Radiol 44:496–502
Riccabona M, Avni F, Damasio B et al (2012) ESPR Uroradiology task force and ESUR Paediatric working group - imaging recommendations in paediatric uroradiology, part V: childhood cystic kidney disease, childhood renal transplantation, and contrast-enhanced ultrasound in children. Pediatr Radiol 42:1275–1283
Riccabona M, Avni F, Dacher JN et al (2011) ESPR uroradiology task force and ESUR paediatric working group: imaging recommendations in paediatric uroradiology, part IV minutes of the ESPR uroradiology task force mini-symposium on imaging in childhood renal hypertension and imaging of renal trauma in children. Pediatr Radiol 41:939–944
Riccabona M, Avni FE, Dacher JN et al (2010) ESPR uroradiology task force and ESUR paediatric working group: Im-aging and procedural recommendations in paediatric uroradiology, part III. Minutes of the ESPR uroradiology task force mini-symposium on intravenous urography, uro-CT and MR-urography in childhood. Pediatr Radiol 40:1315–1320
Riccabona M, Avni FE, Blickman JG et al (2009) Imaging recommendations in paediatric uroradiology, part II: urolithiasis and haematuria in children, paediatric obstructive uropathy, and postnatal work-up of foetally diagnosed high grade hydronephrosis. Minutes of a mini-symposium at the ESPR annual meeting, Edinburgh, Scotland, June. Pediatr Radiol 39:891–898
Riccabona M, Avni FE, Blickman JG et al (2008) Imaging recommendations in paediatric uroradiology: minutes of the ESPR workgroup session on urinary tract infection, fetal hydronephrosis, urinary tract ultrasonography and voiding cystourethrography, Barcelona, Spain, June 2007. Pediatr Radiol 38:138–145
Gastrointestinal ultrasound
Anupindi SA, Halverson M, Khwaja A et al (2014) Common and uncommon applications of bowel ultrasound with pathologic correlation in children. AJR Am J Roentgenol 202:946–959
Chiorean L, Schreiber-Dietrich D, Braden B et al (2015) Ultrasonographic imaging of inflammatory bowel disease in pediatric patients. World J Gastroenterol 21:5231–5241
Gale HI, Gee MS, Westra SJ, Nimkin K (2016) Abdominal ultrasonography of the pediatric gastrointestinal tract. World J Radiol 8:656–667
Lobo ML, Roque M (2014) Gastrointestinal ultrasound in neonates, infants and children. Eur J Radiol 83:1592–1600
Nylund K, Maconi G, Hollerweger A et al (2017) EFSUMB recommendations and guidelines for gastrointestinal ultrasound - part 1: examination techniques and normal findings (long version). Ultraschall Med 38:e1-e15
Pallota N, Civitelli F, DiNardo G et al (2013) Small intestine contrast ultrasonography in pediatric Crohn’s disease. J Pediatr 163:778–784
Riccabona M (2014) US of the gastrointestinal tract. In: Riccabona M (ed) Pediatric ultrasound: requisites and applications. Springer, Berlin, Heidelberg, pp 289–319
Contrast-enhanced ultrasound
Albrecht T, Blomley M, Bolondi L et al (2004) Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 25:249–256
Armstrong LB, Mooney DP, Paltiel H et al (2017) Contrast enhanced ultrasound for the evaluation of blunt pediatric abdominal trauma. J Pediatr Surg 53:548–552
Ascenti G, Zimbaro G, Mazziotti S et al (2004) Harmonic US imaging of vesicoureteric reflux in children: usefulness of a second generation US contrast agent. Pediatr Radiol 34:481–487
Claudon M, Cosgrove D, Albrecht T et al (2008) Guidelines and good practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med 29:28–44
Coleman JL, Navid F, Furman WL, McCarville MB (2014) Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience. AJR Am J Roentgenol 202:966–970
Darge K (2008) Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I. Procedure. Pediatr Radiol 38:40–53
Darge K (2008) Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteral reflux in children. II. Comparison with radiological examinations. Pediatr Radiol 38:54–63
Darge K, Papadopoulou F, Ntoulia A et al (2013) Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the international contrast ultrasound society (ICUS). Pediatr Radiol 43:1063–1073
Jacob J, Deganello A, Sellars ME et al (2013) Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med 34:529–540
Kis E, Nyitrai A, Várkonyi I et al (2010) Voiding urosonography with second-generation contrast agent versus voiding cystourethrography. Pediatr Nephrol 25:2289–2293
Knieling F, Strobel D, Rompel O et al (2016) Spectrum, applicability and diagnostic capacity of contrast-enhanced ultrasound in pediatric patients and young adults after intravenous application - a retrospective trial. Ultraschall Med 37:619–626
McCarville MB, Coleman JL, Guo J et al (2016) Use of quantitative dynamic contrast-enhanced ultrasound to assess response to angiogenetic therapy in children and adolescents with solid malignancies: a pilot study. AJR Am J Roentgenol 206:933–939
Menichini G, Sessa B, Trinci M et al (2015). Accuracy of contrast-enhanced ultrasound (CEUS) in the identification and characterization of traumatic solid organ lesions in children: a retrospective comparison with baseline US and CE-MDCT. Radiol Med 120:989–1001
Papadopoulou F, Ntoulia A, Siomou E, Darge K (2014) Contrast-enhanced voiding urosonography with intravesical administration of a second-generation ultrasound contrast agent for diagnosis of vesicoureteral reflux: prospective evaluation of contrast safety in 1,010 children. Pediatr Radiol 44:719–728
Piscaglia F, Nolsoe C, Dietrich CF et al (2011) The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 32:1–27
Piskunowicz M, Kosiak W, Batko T et al (2015) Safety of intravenous application of second-generation ultrasound contrast agent in children: prospective analysis. Ultrasound Med Biol 41:1095–1099
Riccabona M (2012) Application of a second-generation US contrast agent in infants and children – a European questionnaire-based survey. Pediatr Radiol 42:1471–1480
Riccabona M, Avni FE, Damasio MB et al (2012) ESPR Uroradiology task force and ESUR pediatric working group – imaging recommendations in paediatric uroradiology, part V: childhood cystic kidney disease, childhood renal transplantation and contrast-enhanced ultrasonography in children. Pediatr Radiol 42:1275–1283
Riccabona M, Vivier P, Ntoulia A et al (2014) ESPR uroradiology task force imaging recommendations in paediatric uroradiology, part VII: standardised terminology, impact of existing recommendations, and update on contrast-enhanced ultrasound of the paediatric urogenital tract. Pediatr Radiol 44:1478–1484
Rosado E, Riccabona M (2016) Off-label use of ultrasound contrast agents for intravenous applications in children: analysis of the existing literature. J Ultrasound Med 35:487–496
Seitz K, Strobel D (2016) A milestone: approval of CEUS for diagnostic liver imaging in adults and children in the USA. Ultraschall Med 37:229–232
Sidhu PS, Cantisani V, Deganello A et al (2017) Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38:33–43
Gadolinium
Bussi S, Fouillet X, Morisetti A (2007) Toxicological assessment of gadolinium release from contrast media. Exp Toxicol Pathol 58:323–330
Errante Y, Cirimele V, Mallio CA et al (2014) Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Investig Radiol 49:685–690
Flood TF, Stence NV, Maloney JA et al (2017) Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 282:222–228
Frenzel T, Lengsfeld P, Schirmer H et al (2008) Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Investig Radiol 43:817–828
Hu HH, Pokorney A, Towbin RB et al (2016) Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams. Pediatr Radiol 46:1590–1598
Kanda T, Ishii K, Kawaguchi H et al (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material radiology. Radiology 270:834–841
Kanda T, Osawa M, Oba H et al (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803–809
Klee D, Riccabona M, Born M et al (2017) Informationen der Gesellschaft für Pädiatrische Radiologie zur Verwendung von gadoliniumhaltigem Kontrastmittel für die Kernspintomographie im Kindes- und Jugendalter. (Translation: Information of the society of German speaking paediatric radiologists (GPR) on the use of Gadolinium based contrast agents in childhood). Fortschr Röntgenstr 189: 817–819
Malayeri AA, Brooks KM, Bryant LH et al (2016) National Institutes of Health perspective on reports of gadolinium deposition in the brain. J Am Coll Radiol 13:237–241
McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782
Miller JH, Hu HH, Pokorney A et al (2015) MRI brain signal intensity changes of a child during the course of 35 gadolinium contrast examinations. Pediatrics 136:e1637-e1640
Murata N, Gonzalez-Cuyar LF, Murata K et al (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Investig Radiol 51:447–453
Quattrocchi CC, Mallio CA, Errante Y et al (2015) Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Investig Radiol 50:470–472
Radbruch A, Weberling LD, Kieslich PJ et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275:783–791
Renz DM, Kümpel S, Böttcher J et al (2018) Comparison of unenhanced T1-weighted signal intensitities within the dentate nucleus and the globus pallidus after serial applications of gadopentetate dimeglumine versus gadobutrol in a pediatric population. Investig Radiol 53:119–127
Riccabona M, Olsen OE, Claudon M et al (2008) Gadolinium and nephrogenic systemic fibrosis. In: Fotter R. (ed) Pediatric uroradiology, 2nd edn. Springer, Berlin-Heidelberg-NewYork, pp 515–517
Robert P, Violas X, Grand S et al (2016) Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats. Investig Radiol 51:73–82
Roberts DR, Holden KR (2016) Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast. Brain Dev 38:331–336
Rogosnitzky M, Branch S (2016) Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals 29:365–376
Stojanov D, Aracki-Trenkic A, Benedeto-Stojanov D (2016) Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status. Neuroradiology 58:433–441
Stojanov DA, Aracki-Trenkic A, Vojinovic S et al (2016). Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol 26:807–815
Thomsen HS, Morcos SK, Almén T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR contrast medium safety committee guidelines. Eur Radiol 23:307–318
Thomson HS, Webb AW (eds) (2014) Contrast media: safety issues and ESUR guidelines, 3rd edn. Springer, Berlin-New York
Testicular microlithiasis
Aizenstein RI, Hibbeln JF, Sagireddy B et al (1997) Klinefelter's syndrome associated with testicular microlithiasis and mediastinal germ-cell neoplasm. J Clin Ultrasound 25:508–510
Cooper ML, Kaefer M, Fan R et al (2014). Testicular microlithiasis in children and associated testicular cancer. Radiology 270:857–863
Goede J, Hack WW, van der Voort L (2009). Prevalence of testicular microlithiasis in asymptomatic males 0 to 19 years old. J Urol 182:1516–1520
Heller HT, Oliff MC, Doubilet PM et al (2014). Testicular microlithiasis: prevalence and association with primary testicular neoplasm. J Clin Ultrasound 42:423–426
Marte A, Pintozzi L, Creti G et al (2016) Long-term follow-up of testicular microlithiasis in children and adolescents: multicenter prospective cohort study of the Italian Society of Pediatric Urology. Eur J Pediatr Surg 27:155–160
McGlynn KA, Trabert B (2012) Adolescent and adult risk factors for testicular cancer. Nat Rev Urol 9:339–349
Patel KV, Navaratne S, Bartlett E et al (2016) Testicular microlithiasis: is sonographic surveillance necessary? Single centre 14 year experience in 442 patients with testicular microlithiasis. Ultraschall Med 37:68–73
Pedersen MR, Rafaelsen SR, Møller H et al (2016) Testicular microlithiasis and testicular cancer: review of the literature. Int Urol Nephrol 48:1079–1086
Pourbagher MA, Kilinc F, Guvel S et al (2005) Follow-up of testicular microlithiasis for subsequent testicular cancer development. Urol Int 74:108–11
Richenberg J, Belfield J, Ramchandani P et al (2015) Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee. Eur Radiol 25:323–330
Rosen A, Jayram G, Drazer M, Eggener SE (2011) Global trends in testicular cancer incidence and mortality. Eur Urol 60:374–379
Trout AT, Chow J, McNamara ER et al (2017) Association between testicular microlithiasis and testicular neoplasia: large multicenter study in a pediatric population. Radiology 285:576–583
Volokhina YV, Oyoyo UE, Miller JH (2014) Ultrasound demonstration of testicular microlithiasis in pediatric patients: is there an association with testicular germ cell tumors? Pediatr Radiol 44:50–55
Rights and permissions
About this article
Cite this article
Riccabona, M., Lobo, M.L., Augdal, T.A. et al. European Society of Paediatric Radiology Abdominal Imaging Task Force recommendations in paediatric uroradiology, part X: how to perform paediatric gastrointestinal ultrasonography, use gadolinium as a contrast agent in children, follow up paediatric testicular microlithiasis, and an update on paediatric contrast-enhanced ultrasound. Pediatr Radiol 48, 1528–1536 (2018). https://doi.org/10.1007/s00247-018-4147-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-018-4147-3